Back to search
P
Pfizer
ProbablePFE·Pharmaceuticals
Political party breakdown
Corporate/PAC contributions by recipient party for Pfizer.
$658,000
corporate/PAC spending
Republican
$407,500
62%
Democratic
$245,500
37%
Independent
$2,500
0%
Other
$2,500
0%
Party is taken from the recipient's official filing. Transactions without a disclosed party are labeled Unknown — never inferred.
Where the money went by state
Geographic breakdown of Pfizer's corporate/PAC contributions. Click a state to see the red/blue split and local recipients.
Dem lean Rep leanDarker = more spending
California
$73,500 corporate/PAC to recipients in this state
Democratic
$57,000 · 78%
Republican
$15,000 · 20%
Local recipients
$14,000
BARRAGAN FOR CONGRESS
$9,500
DR. RAUL RUIZ FOR CONGRESS
$8,500
SCOTT PETERS FOR CONGRESS
$7,500
KEVIN MCCARTHY FOR CONGRESS
$7,500
VINCE FONG FOR CONGRESS
$5,000
PETE AGUILAR FOR CONGRESS
$5,000
JIMMY PANETTA FOR CONGRESS
$3,000
BERA FOR CONGRESS
$2,500
KEVIN MULLIN FOR CONGRESS
$2,500
$2,500
JAY OBERNOLTE FOR CONGRESS
$2,500
JULIA BROWNLEY FOR CONGRESS
$1,500
ADAM GRAY FOR CONGRESS
$1,500
KEVIN KILEY FOR CONGRESS
$1,500
MARK TAKANO FOR CONGRESS
$1,500
TED LIEU FOR CONGRESS
$1,500
LICCARDO FOR CONGRESS
$1,000
STAND WITH SANCHEZ
$1,000
LAURA FRIEDMAN FOR CONGRESS
$-1,000
$-5,000
State reflects the recipient's reported state. Contributions without a disclosed state are excluded. Showing all available election cycles.
Political footprint
Money associated with Pfizer, separated by source. No combined totals.
Corporate / PAC
$658,000
381 contributions
Directly attributable to the company or its registered PAC.
Figures reflect committee/PAC spending only. Individual-contributor (Schedule A) data is excluded per FEC commercial-use restrictions. Showing all available election cycles.
Federal only. BuyAligned tracks political money disclosed to the FEC — federal candidates, parties, and PACs. It does not include state- or local-level contributions (e.g., ballot measures, state candidates), which are disclosed to separate state agencies and are out of scope here.
Similar companies by political lean
Consumer competitors of Pfizer and which way their corporate/PAC money leans.
Leans blue
0 shownNo matched peers leaning democratic in our data.
Top political recipients
Where Pfizer's corporate/PAC money went.
| Recipient | Type | Party | Amount | Date |
|---|---|---|---|---|
| LOU CORREA FOR CONGRESSCandidate | Candidate | Democratic | $14,000 | Jun 23, 2025 |
| BILIRAKIS FOR CONGRESSCandidate | Candidate | Republican | $12,500 | Jul 14, 2026 |
| MIKE KELLY FOR CONGRESSCandidate | Candidate | Republican | $11,500 | Sep 23, 2025 |
| CISCOMANI FOR CONGRESSCandidate | Candidate | Republican | $11,000 | Jul 14, 2026 |
| NICOLE FOR NEW YORKCandidate | Candidate | Republican | $10,000 | Apr 30, 2025 |
| GUTHRIE FOR CONGRESSCandidate | Candidate | Republican | $10,000 | Feb 20, 2025 |
| CATHY MCMORRIS RODGERS FOR CONGRESSCandidate | Candidate | Republican | $10,000 | Oct 17, 2023 |
| BARRAGAN FOR CONGRESSCandidate | Candidate | Democratic | $9,500 | Sep 23, 2025 |
| KATHERINE CLARK FOR CONGRESSCandidate | Candidate | Democratic | $9,500 | Jun 23, 2025 |
| RON ESTES FOR CONGRESSCandidate | Candidate | Republican | $9,500 | May 30, 2025 |
Showing 1–10 of 195
Page 1 of 20
Advertisement
PAC activity
Political committees affiliated with this company.
Political organizations
Committees reliably associated with this company.
Lobbying activity
Federal lobbying filings disclosed by Pfizer (LDA / Senate records), kept separate from contributions.
Total disclosed
$65,340,000
Filings
131
Top registrant
PFIZER INC.
$59,240,000
Health Issues · 87Trade (domestic/foreign) · 62Taxation/Internal Revenue Code · 56Medicare/Medicaid · 41Budget/Appropriations · 27
Date
Registrant
Amount
- 2026-06-302nd Quarter - Report 2026MARSHALL & POPP, LLCPharmacy; Copyright/Patent/Trademark; Trade (domestic/foreign); Taxation/Internal Revenue Code$60,000
- 2026-06-302nd Quarter - Report 2026RESOLUTION PUBLIC AFFAIRS, LLCHealth Issues; Medicare/Medicaid$60,000
- 2026-06-302nd Quarter - Report (No Activity) 2026AKIN GUMP STRAUSS HAUER & FELD—$50,000
- 2026-06-302nd Quarter - Report 2026BGR GOVERNMENT AFFAIRSHealth Issues$60,000
- 2026-06-302nd Quarter - Report 2026THE DUBERSTEIN GROUP INC.Budget/Appropriations; Health Issues$60,000
- 2026-06-302nd Quarter - Report 2026FEDERAL HEALTH POLICY STRATEGIESHealth Issues$60,000
- 2026-06-302nd Quarter - Report 2026PFIZER INC.Copyright/Patent/Trademark; Health Issues; Medicare/Medicaid; Taxation/Internal Revenue Code; Trade (domestic/foreign)$1,880,000
- 2026-06-302nd Quarter - Report 2026MILLER STRATEGIES, LLCMedicare/Medicaid; Health Issues; Taxation/Internal Revenue Code; Labor Issues/Antitrust/Workplace$150,000
- 2026-06-302nd Quarter - Report 2026WILLIAMS AND JENSEN, PLLCTrade (domestic/foreign); Budget/Appropriations; Defense; Health Issues; Taxation/Internal Revenue Code; Medicare/Medicaid$60,000
- 2026-06-302nd Quarter - Report 2026TODD STRATEGY GROUPPharmacy; Tariff (miscellaneous tariff bills); Trade (domestic/foreign)$60,000
- 2026-03-311st Quarter - Report 2026THE WASHINGTON TAX & PUBLIC POLICY GROUPTaxation/Internal Revenue Code$110,000
- 2026-03-311st Quarter - Report 2026MARSHALL & POPP, LLCTrade (domestic/foreign); Taxation/Internal Revenue Code; Pharmacy; Copyright/Patent/Trademark$60,000
- 2026-03-311st Quarter - Report 2026PFIZER INC.Copyright/Patent/Trademark; Health Issues; Medicare/Medicaid; Trade (domestic/foreign)$4,420,000
- 2026-03-311st Quarter - Report 2026FEDERAL HEALTH POLICY STRATEGIESHealth Issues$60,000
- 2026-03-311st Quarter - Report (No Activity) 2026AKIN GUMP STRAUSS HAUER & FELD—$50,000
- 2026-03-311st Quarter - Amendment 2026BGR GOVERNMENT AFFAIRSHealth Issues$60,000
- 2026-03-311st Quarter - Report 2026WILLIAMS AND JENSEN, PLLCHealth Issues; Taxation/Internal Revenue Code; Medicare/Medicaid; Trade (domestic/foreign); Budget/Appropriations; Defense$60,000
- 2026-03-311st Quarter - Report 2026MILLER STRATEGIES, LLCMedicare/Medicaid; Health Issues; Taxation/Internal Revenue Code; Labor Issues/Antitrust/Workplace$150,000
- 2026-03-311st Quarter - Report 2026THE DUBERSTEIN GROUP INC.Budget/Appropriations; Health Issues$60,000
- 2026-03-311st Quarter - Report 2026RESOLUTION PUBLIC AFFAIRS, LLCHealth Issues; Medicare/Medicaid$60,000
- 2026-03-311st Quarter - Report 2026TODD STRATEGY GROUPPharmacy; Tariff (miscellaneous tariff bills); Trade (domestic/foreign)$60,000
- 2025-12-314th Quarter - Report 2025BGR GOVERNMENT AFFAIRSHealth Issues$60,000
- 2025-12-314th Quarter - Report 2025ALTRIUS GROUP, LLCTrade (domestic/foreign)$30,000
- 2025-12-314th Quarter - Report 2025MARSHALL & POPP, LLCPharmacy; Copyright/Patent/Trademark; Trade (domestic/foreign); Taxation/Internal Revenue Code$60,000
- 2025-12-314th Quarter - Report 2025FEDERAL HEALTH POLICY STRATEGIESHealth Issues$60,000
Lobbying amounts are income/expense figures reported in each LDA filing and are shown per filing, not summed into the contribution totals above. Showing all available years.
Buy me a coffee
If BuyAligned has been useful, a small tip keeps it independent and ad-free.
Secure checkout via Base44 Payments. You can tip without an account.